DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM. et al.
Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP:First results of the EURAMOS-1 good response randomized controlled trial.
J Clin Oncol 2015;
33: 2279-87
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.